This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TRIL Defiance Trillion Dollar Club Index ETF (TRIL) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisHoldingsTrendsBuy This Stock About Defiance Trillion Dollar Club Index ETF (NASDAQ:TRIL) Get TRIL alerts:Sign Up Key Stats Today's Range$19.82▼$20.0650-Day Range$17.50▼$18.4452-Week Range$5.80▼$20.96Volume3,414 shsAverage Volume1.87 million shsMarket Capitalization$2.10 billionAssets Under Management$1.00 millionDividend YieldN/ANet Expense Ratio0.49%Aggregate RatingN/A ETF Overview Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. Read More Defiance Trillion Dollar Club Index ETF ExpensesTypeTRILAsset Allocation ETFsMulti Asset ETFsNASDAQ ETFsAll ETFsManagement Fee0.49%0.61%0.70%0.54%0.53%Other Expenses0.00%0.33%0.71%0.52%0.56%Total Expense0.49%0.85%1.19%0.74%0.73%Fee Waiver0.00%-0.17%-0.61%-0.50%-0.63%Net Expense0.49%0.78%0.95%0.63%0.60% Receive TRIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Defiance Trillion Dollar Club Index ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRIL ETF News HeadlinesRatio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted RadiotherapeuticsJune 20, 2025 | finance.yahoo.comTrillium Therapeutics Stock Price HistoryMay 26, 2025 | investing.comREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.October 14 at 2:00 AM | Paradigm Press (Ad)When You Look Back in 5 Years, You'll Wish You'd Bought This $2 Trillion Artificial Intelligence (AI) StockJuly 30, 2024 | finance.yahoo.comLeiomyosarcoma Drug Pipeline Report 2023 - ResearchAndMarkets.comNovember 10, 2023 | businesswire.comMirati Therapeutics Stock (NASDAQ:MRTX), Analyst Ratings, Price Targets, PredictionsNovember 8, 2023 | benzinga.comSee More Headlines TRIL ETF - Frequently Asked Questions How were Defiance Trillion Dollar Club Index ETF's earnings last quarter? Defiance Trillion Dollar Club Index ETF (NASDAQ:TRIL) released its quarterly earnings results on Thursday, November, 18th. The biotechnology company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.19) by $0.01. What other stocks do shareholders of Defiance Trillion Dollar Club Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Defiance Trillion Dollar Club Index ETF investors own include NVIDIA (NVDA), Golden Dragon (CPMD), FuelCell Energy (FCEL), Gilead Sciences (GILD), TG Therapeutics (TGTX), Inovio Pharmaceuticals (INO) and Advanced Micro Devices (AMD). Fund Details IssuerDefiance ETFs Fund NameDefiance Trillion Dollar Club Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:TRIL Inception Date9/29/2025 Fund ManagerQiao Duan, Stephen Foy Webwww.trilliumtherapeutics.com Phone(416) 595-0627Fund Focus Asset ClassMulti Asset BenchmarkBITA Trillion Dollar Club Index CategoryStrategy FocusAsset Allocation Development LevelBlended Development RegionGlobal Number of Holdings12 Fund Statistics Assets Under Management$1.00 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorDefiance ETFs, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares104,995,000Beta2.08 Creation Fee$300.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:TRIL) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Trillion Dollar Club Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Defiance Trillion Dollar Club Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
